October 18th 2024
New research better defines the link between cardiovascular disease risk and prevalence of ED per serum ceramide levels.
Infertility/andrology: 78% cite inadequate exposure to subspecialty
July 23rd 2018A review of surgically acquired sperm for assisted reproductive technology and a multicenter study analyzing surgical sperm retrieval rates in men with non-mosaic Klinefelter’s syndrome undergoing micro-TESE were among other AUA 2018 take-homes in infertility/andrology.
AUA ’18: Experts pick this year’s key research
May 8th 2018To help you sift the enormous scientific program and prioritize your schedule at the AUA annual meeting, the editors have called upon Urology Times’ editorial advisory board to identify the key research across multiple areas of the specialty.
Challenging cases in urology: CT indicates germ cell tumor, but no palpable testicular mass present
March 29th 2018A 25-year-old male presents with 4 weeks of intermittent right flank pain occasionally radiating to the testicle. CT shows a 7-cm partially necrotic retroperitoneal mass at the level of the right renal vein and a 2-cm lesion overlaying the right psoas muscle.
Shock waves may change future of ED therapy
November 17th 2017It’s hard to argue against an erectile dysfunction treatment that is potentially disease modifying, is noninvasive, and seems to do no harm. The treatment, low-intensity shock wave therapy, has yet to earn the FDA’s approval but is widely used in other countries. Early results from ongoing U.S. trials are promising.
Current prostate Ca guidelines miss germline variants
October 4th 2017Adherence to current guidelines for genetic testing in men with prostate cancer would miss a sizable proportion of patients with pathogenic germline variants, according to a study presented at the American Society of Clinical Oncology annual meeting in Chicago.